Loading news...
Vera Bradley, Inc. (NASDAQ: VRA - Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $2.29 and traded as high as $2.40. Vera Bradley shares last traded at $2.33, with a volume of 343,195 shares changing hands. Analysts
VRA, GPK and PHG have been added to the Zacks Rank #5 (Strong Sell) List on Jan.15, 2026.
Vera Bradley (NASDAQ: VRA - Get Free Report) and Li Ning (OTCMKTS:LNNGY - Get Free Report) are both retail/wholesale companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Profitability This table compares Vera Bradley and Li
The maker of quilted bags and accessories says it is returning to what makes its products unique after a rebrand turned off consumers.
Vera Bradley maintains a Hold rating due to ongoing topline challenges, operational losses, and significant impairments despite sequential improvement. New management is reversing the failed 2024 rebranding, refocusing on core legacy products, accessible pricing, and digital marketing to recapture historical brand identity. Adjusted 3Q25 results showed a smaller operational loss ($2M) and improved gross margins (51%), but the sustainability of these improvements remains uncertain.
Vera Bradley, Inc. (VRA) Q3 2026 Earnings Call Transcript
Vera Bradley (VRA) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.27 per share a year ago.
Reclaiming Vera Bradley's joyful optimism, while fueling operational excellence Reclaiming Vera Bradley's joyful optimism, while fueling operational excellence
FORT WAYNE, Ind., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced that it plans to report results for the third quarter ending November 1, 2025 of fiscal year 2026 (fiscal year ending January 31, 2026) at 8:00 a.m. Eastern Time on Thursday, December 11, 2025.
FORT WAYNE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ:VRA) today announced the appointment of Ivan Brockman to its Board of Directors effective November 17, 2025.
LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vera Bradley, Inc. (“Vera Bradley” or “the Company”) (NASDAQ: VRA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vera Bradley, Inc. (“Vera Bradley” or “the Company”) (NASDAQ: VRA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
FORT WAYNE, Ind., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ:VRA) today announced the appointment of Melinda Paraie as the Company's Chief Brand Officer effective November 1, 2025.
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public.
ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ: VRA) complied with federal securities laws. On June 11, 2025, Vera Bradley announced financial results for the first quarter of fiscal 2026. The CEO commented on the results, stating they were "disappointing as top line and profitability trends from the previous several quarters continued." Following this news, the price of the Company's stock dropped.
NEW YORK , Oct. 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public. So What: If you purchased Vera Bradley securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
LOS ANGELES , Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Vera Bradley, Inc. ("Vera Bradley" or "the Company") (NASDAQ: VRA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES , Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vera Bradley, Inc. ("Vera Bradley" or "the Company") (NASDAQ: VRA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Savara (NASDAQ: SVRA - Get Free Report) and VYNE Therapeutics (NASDAQ: VYNE - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, dividends, earnings and profitability. Risk and Volatility Savara has a beta of
NEW YORK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public.